SOURCE: Martin Nutraceuticals Inc.

March 07, 2006 10:06 ET

Independent Studies Show Effectiveness of Martin Product

RENO, NV -- (MARKET WIRE) -- March 7, 2006 -- Martin Nutraceuticals Inc. (OTC: MNCL) references new studies that show the effectiveness of using its' proprietary product Arthrizyme™.

According to an article in USA Today (March 2005) arthritis has become one of the most prevalent chronic health problems and North America's leading cause of disability among people over the age of 15. Arthritis is second only to heart disease as a cause of work disability, costing the U.S. economy an estimated 85 million dollars annually. Medical treatment generally consists of non-steroidal anti-inflammatory drugs (NSAID), however this type of treatment has come into question recently due to severe side effects that have been encountered.

Arthrizyme™ is a proteolytic enzyme formula that in double blind studies, has proven to be as effective as NSAID therapy without the side effects. Arthrizyme™ is a proprietary blend of systemic enzymes designed to rapidly reduce inflammation in joints and muscles. Arthrizyme™, however, is not limited to its anti-inflammatory effect, but also assists the body in the healing process by breaking down fibrin in joints and muscles -- Baumuller M. -- The Application of Hydrolytic Enzymes in Soft Tissue Injuries. A Double Blind Study -- allgemeinmedizin-2002;19:178-182.

Harvey Panesar, President of Martin Nutraceuticals Inc. commented, "We are pleased, to say the least, with the results of these independent studies with Arthrizyme™ and its' effect on arthritis sufferers. Dr. Martin has committed the last 15 years of his life to this research and we applaud his efforts."

Dr. Anthony Martin, Martin Nutraceuticals Director of Research, noted that, "I am gratified by these new independent studies which validate my own research and studies over the past 15 years concerning the positive effects of using Arthrizyme™ and its blend of systemic enzymes for the treatment of arthritis. I firmly believe that Arthrizyme™ is one of the most viable, cost effective and reliable natural treatments for sufferers of arthritis."

About Martin Nutraceuticals Inc.

Martin Nutraceuticals Inc. is a company focused on providing a better health and lifestyle through natural products. Martin Nutraceuticals flagship products include Arthrizyme™ for general joint pain and Oxygenol™ for anti-oxidation and Maximum Slim™ for weight control.

Arthrizyme™ is a unique blend of systemic enzymes designed to rapidly reduce inflammation in joints and muscles. Arthrizyme™ is not limited to anti-inflammatory effects; it also assists the body in the healing process by breaking down fibrin in joints and muscles. Arthrizyme™ is Martin's answer to the popular Glucosamine HCL Chondroitin Sulfate blend currently marketed under several different industry names. Arthrizyme™ differs from all other natural arthritis remedies and was designed to work for all types of arthritis and in all joints of the body. Arthrizyme™ is fast acting, usually improving symptoms within the first few days.

Safe Harbor Statement

This release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The risks and uncertainties that may affect the operations, performance development and results of the Company's business include but are not limited to fluctuations in financial results, availability and customer acceptance of our products and services, the impact of competitive products, services and pricing, general market trends and conditions.

Contact Information